Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00131066 · ClinicalTrials.gov registry record
Long-Term Follow-Up Study of Psoriasis Patients
A clinical trial, sponsored by MedImmune.
- Completed
- Registry status
- 200
- Enrollment target
NCT00131066 is a clinical trial that has completed, run by MedImmune. The registered enrollment target is 200 participants.
The verdict
NCT00131066 has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the long-term safety and profile of psoriasis patients who have completed participation in a previous study and who received treatment with MEDI-507.
Interventions
- OTHER Follow up from previous treatment with MEDI-507
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2002-08 |
| Est. Completion | 2007-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00131066
The ClinicalTrials.gov registry entry for NCT00131066 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Follow up from previous treatment with MEDI-507 is the first listed.
NCT00131066 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00131066 about?
NCT00131066 is a clinical study titled "Long-Term Follow-Up Study of Psoriasis Patients". The purpose of this study is to evaluate the long-term safety and profile of psoriasis patients who have completed participation in a previous study and who received treatment with MEDI-507.
What is the current status of trial NCT00131066?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2002-08. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00131066?
The interventions under investigation include: Follow up from previous treatment with MEDI-507 (OTHER).
Who is sponsoring clinical trial NCT00131066?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.